EUVIMEDEUVIMED entdecken
Crossref

Evaluating the Clinical Characteristics and Ophthalmic Manifestations in Children and Adolescents with Acquired Demyelinating Disorders in China

Si-Yuan Li, Chun-Xia Peng, Hua-Xin Zuo, Qi Lin, Ji-Feng Yu, Wen Liu, Li Li, Wei Shi

British Journal of Hospital Medicine · 2025

DOI: 10.12968/hmed.2024.0555 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Hospital Medicine, 2025. Verfasst von Si-Yuan Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China. Hauptthemen laut MEDLINE: Optic Neuritis, Neuromyelitis Optica, Demyelinating Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/Background Pediatric acquired demyelinating disorders (ADS) include various monophasic and recurrent inflammatory conditions of the central nervous system (CNS). Optic neuritis (ON) is a demyelinating disease primarily affecting the optic nerve axons due to autoimmune inflammation. To investigate the clinical characteristics, ophthalmic manifestations, laboratory test results, and prognostic indicators of Chinese children and adolescents with ADS.

Methods

The clinical data of 57 patients with ADS treated in the Beijing Children’s Hospital from March 2021 to December 2023, were retrospectively collected and analyzed. The primary outcomes include best-corrected visual acuity (BCVA) at onset, peripapillary retinal nerve fiber layers (RNFL) thickness, serum myelin oligodendrocyte glycoprotein (MOG) antibody level, aquaporin-4 (AQP4) antibody level, and final BCVA after hormone therapy.

Results

The analyses included 57 children and adolescents in the study, including 38 optic neuritis (ON), 12 neuromyelitis optica spectrum disorder (NMOSD), 5 acute disseminated encephalomyelitis (ADEM), and 2 multiple sclerosis (MS) patients. The median age of patients facing the initial attack of ON was 9 years (3–15 years), with 23 children and adolescents (40.4%) aged eight years or younger, and 37 patients (64.9%) were bilaterally affected. Half of the children and adolescents (15/30) were MOG-Ab seropositive, and 19.4% (6/31) were AQP4-Ab seropositive. Children and adolescents with NMOSD were more likely to have severe visual impairment at acute onset (p < 0.05), with 84.2% of them having low vision acuity (BCVA worse than 0.1), as compared with 64.9% in the ON group. The RNFL thickness of affected eye was thinner than unaffected eyes (median 72.0 μm vs. median 102.0 μm, p < 0.05). Patients with NMOSD exhibited lower RNFL thickness across all measured sectors compared to those with ON. Significant differences were noted in the average RNFL and in each specific region of the retina, including the temporal RNFL, nasal RNFL, nasal superior RNFL, nasal inferior RNFL, temporal superior RNFL, and temporal inferior RNFL (all p < 0.05). After the treatment with intravenous methylprednisolone, both patients with ON (52 eyes; 86.7%) or NMOSD (20 eyes; 90.9%) group had functional visual recovery (BCVA better or equal 0.4).

Conclusion

This study shows that Chinese children and adolescents with ADS present distinctive clinical features, including earlier onset and more bilateral involvement. Furthermore, NMOSD patients experience more severe visual acuity impairment and thinner peripapillary RNFL. All children and adolescents of ON or NMOSD respond well to methylprednisolone treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Optic NeuritisNeuromyelitis OpticaDemyelinating DiseasesHumansChildAdolescentMaleFemaleRetrospective StudiesChinaVisual AcuityChild, PreschoolMyelin-Oligodendrocyte GlycoproteinAquaporin 4AutoantibodiesMultiple SclerosisEncephalomyelitis, Acute Disseminated

Stichwörter der Autor:innen

acquired demyelinating disordersacute disseminated encephalomyelitismultiple sclerosismyelin oligodendrocyte glycoproteinneuromyelitis optica spectrum disorderoptic neuritisperipapillary retinal nerve fiber layers

Substanzen

Myelin-Oligodendrocyte GlycoproteinAquaporin 4Autoantibodies

Autor:innen und Institutionen

  • Department of Ophthalmology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.

Zitieren

APA

Li, S. Y., Peng, C. X., Zuo, H. X., Lin, Q., Yu, J. F., Liu, W., Li, L., & Shi, W. (2025). Evaluating the Clinical Characteristics and Ophthalmic Manifestations in Children and Adolescents with Acquired Demyelinating Disorders in China. British Journal of Hospital Medicine. https://doi.org/10.12968/hmed.2024.0555

Vancouver

Li SY, Peng CX, Zuo HX, Lin Q, Yu JF, Liu W, et al. Evaluating the Clinical Characteristics and Ophthalmic Manifestations in Children and Adolescents with Acquired Demyelinating Disorders in China. British Journal of Hospital Medicine. 2025. doi:10.12968/hmed.2024.0555

BibTeX
@article{Li2025,
  author = {Li, Si-Yuan and Peng, Chun-Xia and Zuo, Hua-Xin and Lin, Qi and Yu, Ji-Feng and Liu, Wen and Li, Li and Shi, Wei},
  title = {Evaluating the Clinical Characteristics and Ophthalmic Manifestations in Children and Adolescents with Acquired Demyelinating Disorders in China},
  journal = {British Journal of Hospital Medicine},
  year = {2025},
  doi = {10.12968/hmed.2024.0555}
}
Kostenlos starten →